Given the link between visceral obesity, insulin resistance, and the risk for diabetes and cardiovascular disease, future studies assessing the body composition and metabolic effects of GH + PIO in adults with the metabolic syndrome may be warranted. This evidence concerns the gene GH1 and cardiovascular disorder.